RCSI researchers discover new way to halt excessive inflammation
RCSI researchers have discovered a new way to ‘put the brakes’ on excessive inflammation by regulating a type of white blood cell that is critical for our immune system.
The discovery has the potential to...
Cervical cancer treatment world first at The Christie
A Stockport woman is set to become the first ever patient in the world to be entirely treated for cervical cancer using a state-of-art radiotherapy treatment at The Christie NHS Foundation Trust.
Karen Hall, 57,...
What happens in our brain when we die
Neuroscientists have recorded the activity of a dying human brain and discovered rhythmic brain wave patterns similar to those during dreaming, memory recall, and meditation. A new study suggests an explanation for vivid life...
Cancer cell ‘switch-off’ could aid deadly brain tumour treatment
Researchers believe they may have found a way to strengthen possible treatments for glioblastoma and reduce the speed at which the aggressive tumour progresses.
Glioblastoma is the most common primary brain tumour in adults, and,...
UK life sciences raised over £10.5bn in investment between 2020 and 2022
UK life sciences companies raised more this impressive sum, driven by the UK’s advanced research and development capabilities.
The total amount of VC investment in the sector was more than that in Germany, France and...
Wireless system can power devices inside the body
New technology could enable remote control of drug delivery, sensing, and other medical applications.
MIT researchers, working with scientists from Brigham and Women’s Hospital, have developed a new way to power and communicate with devices...
£167 million research hub
Imperial College London has opened its biggest new academic building in a generation.
The £167 million Molecular Sciences Research Hub on the College’s White City Campus is the UK’s most significant scientific development since the...
THE FORCE OF LIVING CELLS EXERTED AT WARP SPEED MEASURED
Scientists at the University of St Andrews have learned to measure the tiniest forces living cells exert at sheer WARP speed.
As first published in Nature Communications, the team of researchers, led by the School...
Targetting fast-growing cancer cells
The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells.
Polo-like kinase (PLK1) was previously thought to have a major...
Findings offer hope of a cure
American company Sangamo BioSciences, Inc. has announced the presentation of preclinical data from its ZFP Therapeutic programme for the treatment and potential cure of both sickle cell disease (SCD) and beta-thalassemia.
The data demonstrate that...
Study of problems in OCD helps young people unlock their potential at school
Adolescents with obsessive-compulsive disorder (OCD) have widespread learning and memory problems, according to research published today. The findings have already been used to assist adolescents with OCD obtain the help they needed at school...
Legal Cannabis Market in Europe Set to be Worth €3.2 billion by 2025
The European cannabis market is forecast to grow with a compound annual growth rate (CAGR) of 67.4% to reach €3.2 billion by 2025, a new report has found.
The European Cannabis Report: 6th Edition, released...
The scientific, political and economic implications of COVID-19: an insider’s perspective
It is widely assumed that the life science industry performed well off the back of the COVID-19 pandemic, with the demand for assays and molecular tools driving unprecedented sales to support global research. This...
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875
Next Generation ADC Uses Proprietary Technologies Aimed at Enhancing Cancer Therapy Efficacy and Safety
Nijmegen, The Netherlands – 11 August 2020 – Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients...
New Cell and Gene Therapy Catapult CEO brings continuity and ambition
Matthew Durdy appointed to CEO role as the CGT Catapult prepares to accelerate innovation, growth and productivity, where needed in the UK.
The Board of the Cell and Gene Therapy Catapult (CGT Catapult), a global...
Attitudes to work and reward in biotech have changed – and employers … so...
Work in life sciences has never really been about the money, but the mix of qualities that companies offer – and employees want – changes over time. Singular Talent speaks to over 1,500 candidates...